Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06328426Not yet recruiting
Randomised, double-blind trial of liquid metformin (Aspargo Labs) in osteoarthritis (OA) (3 arms), sponsored by Assiut University. Primary endpoint: Effusion-synovitis volume on musculoskeletal ultrasound at 4 months. Planned start Aug 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06328426.